Fragile X syndrome

Fragile X syndrome, an X-linked dominant disorder with reduced penetrance, is associated with intellectual and emotional disabilities ranging from learning problems to mental retardation, and mood instability to autism. It is most often caused by the transcriptional silencing of the FMR1 gene, due to an expansion of a CGG repeat found in the 5′-untranslated region. The FMR1 gene product, FMRP, is a selective RNA-binding protein that negatively regulates local protein synthesis in neuronal dendrites. In its absence, the transcripts normally regulated by FMRP are over translated. The resulting over abundance of certain proteins results in reduced synaptic strength due to AMPA receptor trafficking abnormalities that lead, at least in part, to the fragile X phenotype.

[1]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[2]  I. Weiler,et al.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. , 2001, American journal of medical genetics.

[3]  A. Reiss,et al.  Psychiatric disorders associated with fragile X in the young female. , 1993, Pediatrics.

[4]  Juliane Hoyer,et al.  Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation , 2006, American journal of medical genetics. Part A.

[5]  H. Moser,et al.  Dendritic anomalies in disorders associated with mental retardation. , 1999, Cerebral cortex.

[6]  B. D. de Vries,et al.  Mental status of females with an FMR1 gene full mutation. , 1996, American journal of human genetics.

[7]  H. Van Esch The Fragile X premutation: new insights and clinical consequences. , 2006, European journal of medical genetics.

[8]  S. Warren,et al.  Characterization of the full fragile X syndrome mutation in fetal gametes , 1997, Nature Genetics.

[9]  D. Dawson,et al.  Do young boys with fragile X syndrome have macroorchidism? , 1994, Pediatrics.

[10]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[11]  W. Brown,et al.  Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. , 1994, JAMA.

[12]  J. Sutcliffe,et al.  DNA methylation represses FMR-1 transcription in fragile X syndrome. , 1992, Human molecular genetics.

[13]  J. Brunberg,et al.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. , 2004, JAMA.

[14]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[15]  R. Hagerman Lessons from Fragile X Regarding Neurobiology, Autism, and Neurodegeneration , 2006, Journal of developmental and behavioral pediatrics : JDBP.

[16]  J. Wilding,et al.  Annotation: Deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach. , 2004, Journal of child psychology and psychiatry, and allied disciplines.

[17]  B. Maes,et al.  Phenotypic checklist to screen for fragile X syndrome in people with mental retardation. , 2000, Mental retardation.

[18]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[19]  M. Leboyer,et al.  Genotype–phenotype relationship in female carriers of the premutation and full mutation of FMR-1 , 1998, Psychiatry Research.

[20]  J. Opitz,et al.  Consideration of connective tissue dysfunction in the fragile X syndrome. , 1984, American journal of medical genetics.

[21]  A. Taylor,et al.  Molecular-clinical correlations in males with an expanded FMR1 mutation. , 1996, American journal of medical genetics.

[22]  W. Brown,et al.  Neuropsychiatric Symptoms of Fragile X Syndrome , 2004, CNS drugs.

[23]  Mark F. Bear,et al.  Correction of Fragile X Syndrome in Mice , 2007, Neuron.

[24]  W. Brown,et al.  Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. , 2003, American journal of human genetics.

[25]  Stephen J. Guter,et al.  Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. , 2006, Journal of child and adolescent psychopharmacology.

[26]  W. Brown,et al.  Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. , 1993, American journal of human genetics.

[27]  Dana C Crawford,et al.  FMR1 and the fragile X syndrome: Human genome epidemiology review , 2001, Genetics in Medicine.

[28]  A. Chaudhuri,et al.  Neuroanatomical, molecular genetic, and behavioral correlates of fragile X syndrome , 2007, Brain Research Reviews.

[29]  Karolina Nilsson,et al.  Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications. , 2005, Current topics in medicinal chemistry.

[30]  W. Brown,et al.  Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.

[31]  Stephen T Warren,et al.  Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors , 2007, Proceedings of the National Academy of Sciences.

[32]  J. Opitz,et al.  An analysis of autism in fifty males with the fragile X syndrome. , 1986, American journal of medical genetics.

[33]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[34]  E. Berry-Kravis,et al.  Psychopharmacology in fragile X syndrome--present and future. , 2004, Mental retardation and developmental disabilities research reviews.

[35]  W. Kaufmann,et al.  Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors , 2004, American journal of medical genetics. Part A.

[36]  W. Brown,et al.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. , 1999, American journal of medical genetics.

[37]  Sufen Chiu,et al.  Recommendations from Multi-disciplinary Focus Groups on Cascade Testing and Genetic Counseling for Fragile X-associated Disorders , 2007, Journal of Genetic Counseling.

[38]  R. Hagerman,et al.  Cognitive profiles of boys with the fragile X syndrome. , 1988, American journal of medical genetics.

[39]  D. Loesch,et al.  Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation , 2006, Journal of developmental and behavioral pediatrics : JDBP.

[40]  D. Driscoll,et al.  Fragile X syndrome: Diagnostic and carrier testing , 2005, Genetics in Medicine.

[41]  A. Reiss,et al.  Biological and environmental contributions to adaptive behavior in fragile X syndrome , 2003, American journal of medical genetics. Part A.

[42]  S. Thibodeau,et al.  Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. , 1993, American journal of human genetics.

[43]  P. Bosco,et al.  Epilepsy and EEG Findings in Males with Fragile X Syndrome , 1999, Epilepsia.

[44]  R. Bennett,et al.  Genetic Counseling for Fragile X Syndrome: Updated Recommendations of the National Society of Genetic Counselors , 2005, Journal of Genetic Counseling.

[45]  Karel Svoboda,et al.  Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.

[46]  P. Hagerman,et al.  Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1 , 2007, The Lancet Neurology.

[47]  S. Warren,et al.  Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. , 2001, Human molecular genetics.

[48]  R. Hagerman,et al.  Recurrent otitis media in the fragile X syndrome. , 1987, American journal of diseases of children.

[49]  B. Oostra,et al.  FXTAS: A progressive neurologic syndrome associated with fragile X premutation , 2005, Current neurology and neuroscience reports.

[50]  P. Hagerman,et al.  The fragile-X premutation: a maturing perspective. , 2004, American journal of human genetics.

[51]  N. E. Morton,et al.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males , 2004, Human Genetics.

[52]  J. Opitz,et al.  Fragile X and autism: a multicenter survey. , 1986, American journal of medical genetics.